LAI Transition Planner

This tool was built specifically to align with the California Department of State Hospitals Psychotropic Medication Operational Procedures (updated 8/26/2026), the internal medication guidelines of the California Department of State Hospitals (DSH), and is intended for their use only. This interactive, browser-based calculator is designed to assist clinicians in planning transitions between long-acting injectable antipsychotics in accordance with current DSH clinical policy. It can generate a proposed transition schedule and oral overlap requirements based on clinician-entered patient factors.

The schedules assume that the patient is clinically stable, there is no urgency to complete the transition, and the clinician intends to switch to an approximately equivalent dose rather than increase or decrease the overall antipsychotic dose. The current version supports transitions only among risperidone/paliperidone and aripiprazole-based products and should not be used for cross-molecule switches to other antipsychotics. The tool does not make clinical decisions, account for individual medical complexity, or replace clinical judgment or direct patient evaluation.

Current LAI

Dosing interval
Current dose
Doses received to date
Date of last injection

Switching to

Maintenance interval
Target dose
Select the current medication and the medication being switched to.

Recommended plan

Transition timeline

Disclaimer

This tool provides information which may support clinical decision-making. It does not serve as a guideline for individual patient management and does not replace clinical judgment or local protocols. Ultimate treatment decisions must be made by the treating clinician considering individual patient factors and clinical data and relying upon their professional judgment. This tool does not provide guidance for doses that have been missed. The schedules generated here assume the current long-acting injectable has been administered on time and as prescribed. If a scheduled injection has been missed or delayed, do not rely on this output; refer to the product labeling and institutional protocol, or request a consultation.

Some information presented within this tool was created in collaboration with the California Department of State Hospitals (DSH). This includes that the content has been specifically aligned to the DSH medication guidelines. These medication guidelines are applicable only to the DSH settings and inclusion within this resource does not necessarily indicate that they should be followed in any non-DSH settings. The medication guidelines included in this resource are those of DSH and do not necessarily represent the views, policy or positions of the American Psychiatric Association (APA).

Go to top of page